SynopsisThe global Recombinant Erythropoietin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Recombinant Erythropoietin is estimated.....
SynopsisThe global Tissue Sealants and Tissue Adhesive market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Tissue Sealants and Tissue Adh.....
SynopsisThe global Liquid Combination Hib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030. North American market for Liquid Combination Hib is estimated to incre.....
SynopsisDecitabine is also known as 5 - nitrogen hetero - 2 '- DNA cytosine nucleoside, 5 - n - 2' - deoxy cytidine acid, is a kind of natural 2 '- deoxy cytidine acid adenosine analogues, by inhibiting the DNA methyltransferase, reduce DNA methylation, thus inhibitin.....
SynopsisFavipiravir, sold under the brand name Avigan, is an antiviral medication used to treat influenza in Japan. It is also being studied to treat a number of other viral infections. Like the experimental antiviral drugs (T-1105 and T-1106), it is a pyrazinecarboxa.....
SynopsisThe global Thymopentin for Injection market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while est.....
SynopsisRosuvastatin calcium (CAS 147098-20-2, molecular formula being C44H54CaF2N6O12S2) is the active pharmaceutical ingredient for the once-a-day dyslipidaemia treatment Crestor, it is one approved API which can be used to reduce the risk of heart attack and stroke.....
SynopsisThe global Functional Electrical Stimulation (FES) System market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were.....
SynopsisThe global Reusable Surgical Instrument market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Reusable Surgical Instrument in various end use industries. T.....
Synopsis Global Upper Extremity Implants market is projected to reach US$ 2265.3 million in 2029, increasing from US$ 1486 million in 2022, with the CAGR of 6.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-1.....
